Research Priorities

1. Prevalence and Incidence Studies

 Establishing accurate epidemiological data through large-scale, methodologically rigorous population studies.

2. Advance Diagnostic & Distinction Instruments

Creating standardized, validated diagnostic and distinction criteria, building on existing diagnostic criteria, to further assessment tools for clinical and research use; to improve diagnosis, enable consistent research, and advance clinical care worldwide.

3. Pathophysiology Investigation

 Understanding the molecular and cellular mechanisms underlying persistent sexual dysfunction post-SSRI treatment.

4. Treatment Research

Research on possible medical interventions for symptom management

Collaboration Opportunities

For Researchers

We welcome collaboration with investigators in relevant fields including:

• Neuropharmacology and psychopharmacology

• Sexual medicine and reproductive health

• Neuroscience and neuroimaging

• Epidemiology and biostatistics

• Clinical psychology and psychiatry
  

For Institutions and Ethics Boards

We seek partnerships with:

• Academic medical centers for clinical trial sites

• Research institutions for laboratory-based studies

• Ethics review boards for study oversight and guidance

• Regulatory agencies for treatment development pathways